Caricamento...

Administration of apo A-I (Milano) nanoparticles reverses pathological remodelling, cardiac dysfunction, and heart failure in a murine model of HFpEF associated with hypertension

Therapeutic interventions with proven efficacy in heart failure with reduced ejection fraction (HFrEF) have been unsuccessful in heart failure with preserved ejection fraction (HFpEF). The modifiable risk factor with the greatest impact on the development of HFpEF is hypertension. The objectives of...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Sci Rep
Autori principali: Mishra, Mudit, Muthuramu, Ilayaraja, Kempen, Herman, De Geest, Bart
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group UK 2020
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7239951/
https://ncbi.nlm.nih.gov/pubmed/32433476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-65255-y
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !